TH1501005500A - Bispecific Molecules (BISPECIFIC MOLECULES) that are sensitive to immune reactions. with immune effector cells that express activated receptors and antigens expressed by cells infected by the virus and its use. - Google Patents

Bispecific Molecules (BISPECIFIC MOLECULES) that are sensitive to immune reactions. with immune effector cells that express activated receptors and antigens expressed by cells infected by the virus and its use.

Info

Publication number
TH1501005500A
TH1501005500A TH1501005500A TH1501005500A TH1501005500A TH 1501005500 A TH1501005500 A TH 1501005500A TH 1501005500 A TH1501005500 A TH 1501005500A TH 1501005500 A TH1501005500 A TH 1501005500A TH 1501005500 A TH1501005500 A TH 1501005500A
Authority
TH
Thailand
Prior art keywords
bispecific molecules
virus
sensitive
immune
antigens expressed
Prior art date
Application number
TH1501005500A
Other languages
Thai (th)
Other versions
TH178070A (en
Inventor
โคนิกจอห์นสัน เลสลี่ เอสแลม เจีย หยิง เกาหลิว ลี่คินเจฟฟรีย์ ลี นอร์ดสตรอมบาร์ตัน เอฟ เฮเนสกุยโด เฟอร์รารี สกอตต์
Original Assignee
มาโครเจนิคส์ อิงค์ดุค ยูนิเวอร์ซิตี้
Filing date
Publication date
Application filed by มาโครเจนิคส์ อิงค์ดุค ยูนิเวอร์ซิตี้ filed Critical มาโครเจนิคส์ อิงค์ดุค ยูนิเวอร์ซิตี้
Publication of TH1501005500A publication Critical patent/TH1501005500A/en
Publication of TH178070A publication Critical patent/TH178070A/en

Links

Abstract

; ;

TH1501005500A 2014-03-13 Bispecific molecules (BISPECIFIC MOLECULES) that are susceptible to immune reactions. With an immunosuppressant, a cell with an expression of an active receptor And antigens expressed by cells infected by viruses and their use TH178070A (en)

Publications (2)

Publication Number Publication Date
TH1501005500A true TH1501005500A (en) 2018-07-19
TH178070A TH178070A (en) 2018-07-19

Family

ID=

Similar Documents

Publication Publication Date Title
DK3400290T3 (en) Oncolytic virus strain
KR102355950B9 (en) Antibodies to TIGIT
IL251563B (en) Antibody molecules to pd-l1 and uses thereof
CL2016002455A1 (en) Multispecific antibodies.
CL2017000559A1 (en) Combination therapies with anti-cd38 antibodies.
CL2016001879A1 (en) Human antibodies to pd-l1
DK3149042T3 (en) PD-L1 antibodies and uses thereof
DK3191517T3 (en) CROSS-REACTIVE SIGLEC ANTIBODIES
DK3134432T3 (en) CHEMICAL ANTIGEN RECEPTORS WITH MND PROMOTERS
DK3161007T3 (en) MULTI-SPECIFIC ANTIBODY CONSTRUCTS
IL241487B (en) Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
DK3628687T3 (en) CHIMARY BCMA ANTIGEN RECEPTORS
DK3108000T3 (en) Adeno-associated virus vector
EA201791029A1 (en) ANTIBODIES AGAINST INTERLEUKIN-33 AND THEIR APPLICATION
DK3194434T3 (en) CHEMICAL ANTIGEN RECEPTORS
CL2016001102A1 (en) Novel anti-claudin antibodies and methods of use.
BR112017001385A2 (en) anti-pd-1 antibodies
DK3229838T3 (en) Anti-C10orf54 antibodies and uses thereof
DK3126388T3 (en) Anti-EGFRvIII antibodies and uses thereof
BR112016016020A2 (en) antibodies directed against interleukin-33 (il-33)
EA201591750A1 (en) ANTIBODIES AGAINST B7-H4 AND IMMUNOCONJUGATES
CL2016001742A1 (en) Novel anti-baff antibodies
DK3113797T3 (en) ANTIBODIES, USES AND METHODS
EP3218397B8 (en) Neutralizing antibodies to ebola virus glycoprotein and their use
DK3116530T3 (en) IFN-alpha subtype hybrid